Skip to content
You are not logged in |Login  
Limit search to available items
Record:   Prev Next
More Information
BookPrinted Material
Author Sánchez-Serrano, Ibis.

Title The world's health care crisis : from the laboratory bench to the patient's bedside / by Ibis Sánchez-Serrano.

Imprint London ; Waltham, MA : Elsevier, 2011.

Item Status

Location Call No. Status OPAC Message Public Note Gift Note
 Moore Stacks  RA410.5 .S26 2011    Available  ---
Edition 1st ed.
Description xxiii, 271 p. : ill. ; 24 cm.
Series Elsevier insights
Elsevier insights.
Bibliography Includes bibliographical references (p. [269]-271).
Contents Part I: The Global Health Care Crisis.-- 1. The world's health care crisis : the United States' leadership -- The US Health Care Crisis -- The US Health Care System -- 2. The health care crisis in other parts of the world -- The French Health Care System -- The UK Health Care System -- Private insurance use in Europe -- Other industrialized nations -- The developing world: in search of hope -- The pharmaceutical industry -- Part II: Understanding the biopharmaceutical business. -- 3. A brief commercial history of the biopharmaceutical industry up to the year 2000 -- The pharmaceutical industry begins -- The Swiss pharmaceutical industry -- The English pharmaceutical players -- The United State enters the scene -- Impact of World War I (1914-18) -- Impact of World War II (1939-45) -- The Biotechnology Era -- Regulatory pathways for biotechnology -- 4. The biopharmaceutical industry in the twenty-first century : titanic challenges ahead -- The biotechnology business crisis -- The biopharmaceutical industry's short-term solutions to the crisis -- 5. Understanding research and development and marketing in a biopharmaceutical company -- Drug discovery -- Drug development -- Regulators -- Intellectual property -- Conducting clinical trials -- Types of drugs -- Generic drugs -- Pricing -- Marketing -- 6. The pharmaceutical regulators -- Causes of the drug approval lag -- FDA and EMEA initiatives to optimize drug approval -- FDA Critical Path Initiative -- EMEA's road map to 2010 -- The FDA Amendment Act of 2007 -- Part III: The complexity of innovation. -- 7. The academia : industry relationship -- 8. Translating academic innovation into health care products -- Translating basic discoveries into commercial products venture capitalists -- Challenges in translating innovation into commercial products -- Intellectual Property Rights -- Taxpayers' money for innovation and commercial applications -- Important implications for the developing world -- 9. The biotechnology world and its challenges -- 10. Causes of the pharmaceutical crisis -- Drug discovery and development before biotechnology -- Impact of biotechnology in drug discovery and developement -- Part IV: Morality and duty on a lonely planet. -- 11. Wealth versus poverty -- Medicines for the developing world: yes, this is our problem -- Bridging the gap? -- Going beyond business -- 12. Social responsibility, governmental role, and nongovernmental organizations -- Part V: Reinventing research and development. -- 13. Time for reorganization -- Reorganization of research and development at the industrial level -- Translational research -- Suggestions for improving the system -- Conclusion: Future trends.
Summary At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries. Examines the health care structure of the United States, Europe, and the third world, both separately and comparatively offers primary source insight through in-depth interviews with pharmaceutical and health care industry leaders from around the world. Carefully explains, in clear terms, the intricacies of the health care and pharmaceutical system and how these intricacies have led to the current crisis. Offers concrete, comprehensive solutions to the health care crisis.
Subject Medical care.
Health care reform.
Medical ethics.
Social medicine.
ISBN 9780123918758 (hbk.)
0123918758 (hbk.)